This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://www.isscr.org/isscr-news/encellin-announces-new-phase-1-clinical-progress-at-isscr-2026-showing-early-evidence-of-non-fibrotic-engraftment-of-cell-therapy-implant-for-type-1-diabetes